Articles & Video
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
HCP Promotional Engagement Benchmarks Report — Special Edition: Pre-Pandemic Snapshot and COVID-19 Impact Evaluation
This year’s annual analysis of life sciences promotional speaker programming
data is quite different from previous years’ snapshots. The COVID-19 pandemic
has upended industries around the world; life sciences is no exception.
Independent Charitable Copay Foundation Donations: What to Consider and Steps to Take Before Donating and What Recent Court Challenges Might Mean for Industry
From our recent Patient Support Services 2020, Katherine Chaurette of Blueprint Medicines and Rahul Khara of Acceleron Pharma Inc. dive into an overview and brief background of the OIG Guidance, manufacturer and foundation enforcement actions, compliance considerations and so much more in this presentation on Independent Charitable Copay Foundation Donations.
Pricing & Reimbursement US 2020
Whether a drug product is covered, and at what price, is determined by each payer’s coverage, coding, and payment criteria for health insurance plans. The largest government-funded
programs are Medicare and Medicaid, under which plans are subject to detailed requirements set forth by statute or regulation.